{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:16:37Z","timestamp":1780488997076,"version":"3.54.1"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973320"],"award-info":[{"award-number":["81973320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0011\/2020\/A1"],"award-info":[{"award-number":["0011\/2020\/A1"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0021\/2020\/AGJ"],"award-info":[{"award-number":["0021\/2020\/AGJ"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.112957","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T17:20:58Z","timestamp":1650561658000},"page":"112957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Update of Indoles: Promising molecules for ameliorating metabolic diseases"],"prefix":"10.1016","volume":"150","author":[{"given":"Wei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Zhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112957_bib1","first-page":"1","article-title":"You are what you eat - the relationship between diet, microbiota, and metabolic disorders-a review","volume":"12","author":"Moszal","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2022.112957_bib2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2012.04.019","article-title":"Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet","volume":"15","author":"Hatori","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.112957_bib3","first-page":"1415","article-title":"The metabolic syndrome","volume":"366","author":"Robert","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.112957_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.biopha.2022.112957_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.15537\/1658-3175.2863","article-title":"The global epidemic of the metabolic syndrome","volume":"26","author":"Elabbassi","year":"2005","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.biopha.2022.112957_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2022.112957_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41574-020-0334-z","article-title":"Young-onset type 2 diabetes mellitus - implications for morbidity and mortality","volume":"16","author":"Magliano","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2022.112957_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1389557517666170807123201","article-title":"Recent progress in biological activities of Indole and Indole Alkaloids","volume":"18","author":"Singh","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib9","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.celrep.2014.10.032","article-title":"Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells","volume":"9","author":"Chimerel","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2022.112957_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bioorg.2018.08.010","article-title":"New indole based hybrid oxadiazole scaffolds with N-substituted acetamides: as potent anti-diabetic agents","volume":"81","author":"Nazir","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib11","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome Find the latest version: Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2022.112957_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.07.009","article-title":"Synthesis, \u03b1-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: as potential leads for the management of type-II diabetes mellitus","volume":"74","author":"Taha","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2307\/3870057","article-title":"Alkaloid biosynthesis - the basis of metabolic engineering of medicinal plants","volume":"7","author":"Kutchan","year":"1995","journal-title":"Plant Cell"},{"key":"10.1016\/j.biopha.2022.112957_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1146\/annurev.arplant.59.032607.092730","article-title":"Alkaloid biosynthesis: metabolism and trafficking","volume":"59","author":"Ziegler","year":"2008","journal-title":"Annu. Rev. Plant Biol."},{"key":"10.1016\/j.biopha.2022.112957_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2020.104558","article-title":"Indole alkaloids: 2012 until now, highlighting the new chemical structures and biological activities","volume":"143","author":"Rosales","year":"2020","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2022.112957_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/endo-59-3-369","article-title":"The hypoglycemic and insulinase-inhibitory action of some plant growth regulators","volume":"59","author":"Mirsky","year":"1956","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2022.112957_bib17","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.tips.2020.09.013","article-title":"Drug mimicry: promiscuous receptors PXR and AhR, and microbial metabolite interactions in the intestine","volume":"41","author":"Dvo\u0159\u00e1k","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2022.112957_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.immuni.2018.07.010","article-title":"The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity","volume":"49","author":"Metidji","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.112957_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.gastro.2010.03.033","article-title":"A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis","volume":"139","author":"Lee","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.112957_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3177\/jnsv.58.415","article-title":"L-tryptophan suppresses rise in blood glucose and preserves insulin secretion in type-2 diabetes mellitus rats","volume":"58","author":"Inubushi","year":"2012","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"10.1016\/j.biopha.2022.112957_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114514000440","article-title":"Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice","volume":"112","author":"Ritze","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.biopha.2022.112957_bib22","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/0006-2952(79)90196-5","article-title":"Inhibition of hepatic gluconeogenesis by tryptophan metabolites in rats and guinea pigs","volume":"28","author":"Smith","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112957_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-008-1116-9","article-title":"Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats","volume":"198","author":"Bortolato","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2022.112957_bib24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/jcb.22189","article-title":"Linking chronic tryptophan deficiency with impaired bone metabolism and reduced bone accrual in growing rats","volume":"107","author":"Sibilia","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2022.112957_bib25","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic diet\u2013induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.112957_bib26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.celrep.2017.01.062","article-title":"Host genotype and gut microbiome modulate insulin secretion and diet-induced metabolic phenotypes","volume":"18","author":"Kreznar","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2022.112957_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav1892","article-title":"The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs","volume":"11","author":"Virtue","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108384","article-title":"Supplementation of endogenous Ahr ligands reverses insulin resistance and associated inflammation in an insulin-dependent diabetic mouse model","volume":"83","author":"Liu","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2022.112957_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.0906112107","article-title":"The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation","volume":"107","author":"Bansal","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.112957_bib30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.aah5825","article-title":"Lactobacillus reuteri induces gut intraepithelial CD4+CD8\u03b1\u03b1+ T cells","volume":"357","author":"Cervantes-Barragan","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112957_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41591-018-0060-4","article-title":"Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health","volume":"24","author":"Laurans","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.tim.2015.08.001","article-title":"Roles of indole as an interspecies and interkingdom signaling molecule","volume":"23","author":"Lee","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.biopha.2022.112957_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1788899","article-title":"Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity","volume":"12","author":"Dong","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2022.112957_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.201911621","article-title":"Targeting the pregnane X receptor using microbial metabolite mimicry","volume":"12","author":"Dvo\u0159\u00e1k","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib35","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1096\/fj.201800544","article-title":"The gut microbiota metabolite indole alleviates liver inflammation in mice","volume":"32","author":"Beaumont","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2022.112957_bib36","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/jn\/nxab032","article-title":"Hepatoprotective effects of indole, a gut microbial metabolite, in leptin-deficient obese mice","volume":"151","author":"Knudsen","year":"2021","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2022.112957_bib37","first-page":"1","article-title":"Indole alleviates diet-induced hepatic steatosis and inflammation in a manner involving myeloid cell 6-phosphofructo-2-kinase\/Fructose-2,6-biphosphatase 3","volume":"0","author":"Ma","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.112957_bib38","first-page":"262","article-title":"The hypoglycemic action of insulinase-inhibitors by mouth in patients with diabetes mellitus","volume":"69","author":"Diengott","year":"1956","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"10.1016\/j.biopha.2022.112957_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3181\/00379727-100-24562","article-title":"\u201cplasma Insulin Activity\u201d in human diabetes during hypoglycemic response to tolbutamide and indole-3-acetic acid","volume":"100","author":"Smith","year":"1959","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","article-title":"Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"23","author":"Krishnan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2022.112957_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092062","article-title":"Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2022.112957_bib42","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41564-021-00912-0","article-title":"Gut microbiome alterations in high-fat-diet-fed mice are associated with antibiotic tolerance","volume":"6","author":"Liu","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.biopha.2022.112957_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cmet.2018.07.001","article-title":"Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome","volume":"28","author":"Natividad","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.112957_bib44","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature24661","article-title":"A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites","volume":"551","author":"Dodd","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.112957_bib45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","article-title":"Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and toll-like receptor 4","volume":"41","author":"Venkatesh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.112957_bib46","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/oby.2011.251","article-title":"Intestinal permeability is associated with visceral adiposity in healthy women","volume":"19","author":"Gummesson","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.biopha.2022.112957_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu11030591","article-title":"Indole-3-propionic acid, a tryptophan-derived bacterial metabolite, reduces weight gain in rats","volume":"11","author":"Konopelski","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2022.112957_bib48","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/13813455.2017.1398262","article-title":"The microbial metabolite indole-3-propionic acid improves glucose metabolism in rats, but does not affect behaviour","volume":"124","author":"Abildgaard","year":"2018","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2022.112957_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep46337","article-title":"Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the finnish diabetes prevention study","volume":"7","author":"De Mello","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.112957_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41387-018-0046-9","article-title":"Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals","volume":"8","author":"Tuomainen","year":"2018","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.biopha.2022.112957_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nmo.13178","article-title":"Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo","volume":"30","author":"Jennis","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.biopha.2022.112957_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-019-0304-5","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nut.2010.09.006","article-title":"Antiobesity activities of indole-3-carbinol in high-fat-diet-induced obese mice","volume":"27","author":"Chang","year":"2011","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2022.112957_bib54","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jnutbio.2011.12.005","article-title":"Indole-3-carbinol prevents diet-induced obesity through modulation of multiple genes related to adipogenesis, thermogenesis or inflammation in the visceral adipose tissue of mice","volume":"23","author":"Choi","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2022.112957_bib55","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jnutbio.2012.11.007","article-title":"Involvement of SIRT1-AMPK signaling in the protective action of indole-3-carbinol against hepatic steatosis in mice fed a high-fat diet","volume":"24","author":"Choi","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2022.112957_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biochi.2014.06.010","article-title":"Indole-3-carbinol, a vegetable phytochemical, inhibits adipogenesis by regulating cell cycle and AMPK\u03b1 signaling","volume":"104","author":"Choi","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2022.112957_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mnfr.201700119","article-title":"3,3\u2019-Diindolylmethane suppresses high-fat diet-induced obesity through inhibiting adipogenesis of pre-adipocytes by targeting USP2 activity","volume":"61","author":"Yang","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2022.112957_bib58","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s13105-014-0332-5","article-title":"Attenuation of hyperglycemia-mediated oxidative stress by indole-3-carbinol and its metabolite 3, 3\u2032-diindolylmethane in C57BL\/6J mice","volume":"70","author":"Jayakumar","year":"2014","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2022.112957_bib59","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/oby.22145","article-title":"3,3\u2032-diindolylmethane enhances glucose uptake through activation of insulin signaling in 3T3-L1 adipocytes","volume":"26","author":"Choi","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.biopha.2022.112957_bib60","first-page":"1","article-title":"Amelioration of hyperglycemia-induced nephropathy by 3,3\u2032-diindolylmethane in diabetic mice","volume":"24","author":"M.C","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.112957_bib61","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/s41366-019-0340-1","article-title":"Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity","volume":"43","author":"Lin","year":"2019","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2022.112957_bib62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-079X.2005.00287.x","article-title":"Diabetic goto kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status","volume":"40","author":"Peschke","year":"2006","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2022.112957_bib63","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/jama.2013.2710","article-title":"Melatonin secretion and the incidence of type 2 diabetes","volume":"309","author":"McMullan","year":"2013","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.biopha.2022.112957_bib64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jpi.12157","article-title":"Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle","volume":"57","author":"Teodoro","year":"2014","journal-title":"J. Pineal. Res."},{"key":"10.1016\/j.biopha.2022.112957_bib65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1600-079X.2009.00720.x","article-title":"Melatonin ameliorates high fat diet-induced diabetes and stimulates glycogen synthesis via a PKC\u03b6-Akt-GSK3\u03b2 pathway in hepatic cells","volume":"47","author":"Shieh","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2022.112957_bib66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1152\/ajpendo.00094.2013","article-title":"Melatonin acts through MT1\/MT2 receptors to activate hypothalamic Akt and suppress hepatic gluconeogenesis in rats","volume":"305","author":"Faria","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.112957_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jpi.12584","article-title":"Melatonin alleviates cognition impairment by antagonizing brain insulin resistance in aged rats fed a high-fat diet","volume":"67","author":"Xu","year":"2019","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2022.112957_bib68","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.biopha.2017.05.035","article-title":"Melatonin supplementation plus exercise behavior ameliorate insulin resistance, hypertension and fatigue in a rat model of type 2 diabetes mellitus","volume":"92","author":"Rahman","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112957_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jpi.12399","article-title":"Melatonin prevents obesity through modulation of gut microbiota in mice","volume":"62","author":"Xu","year":"2017","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2022.112957_bib70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-079X.2006.00346.x","article-title":"Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats","volume":"41","author":"Pan","year":"2006","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2022.112957_bib71","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1600-079X.2009.00676.x","article-title":"Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats","volume":"46","author":"Tahan","year":"2009","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2022.112957_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20587384211036819","article-title":"Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db\/db mice","volume":"35","author":"Yu","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112957_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-016-0370-9","article-title":"Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK\/P38 signaling in high-fat-diet-induced obese mice","volume":"15","author":"Sun","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2022.112957_bib74","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1111\/jpi.12493","article-title":"Melatonin improves insulin resistance and hepatic steatosis through attenuation of alpha-2-HS-glycoprotein","volume":"65","author":"Heo","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2022.112957_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jpi.12611","article-title":"Melatonin safeguards against fatty liver by antagonizing TRAFs-mediated ASK1 deubiquitination and stabilization in a \u03b2-arrestin-1 dependent manner","volume":"67","author":"Li","year":"2019","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2022.112957_bib76","first-page":"1","article-title":"Melatonin effects on non-alcoholic fatty liver disease are related to microRNA-34a-5p\/Sirt1 axisand autophagy","volume":"8","author":"Are","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.112957_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jpi.12450","article-title":"Effects of melatonin on fatty liver disease: the role of NR4A1\/DNA-PKcs\/p53 pathway, mitochondrial fission, and mitophagy","volume":"64","author":"Zhou","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2022.112957_bib78","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1210\/er.2018-00283","article-title":"Emerging roles for serotonin in regulating metabolism: new implications for an ancient molecule","volume":"40","author":"Yabut","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.biopha.2022.112957_bib79","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nn.3211","article-title":"Unraveling the brain regulation of appetite: lessons from genetics","volume":"15","author":"Yeo","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2022.112957_bib80","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/oby.2012.66","article-title":"Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study","volume":"20","author":"O\u2019Neil","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/j.biopha.2022.112957_bib81","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.gastro.2015.05.020","article-title":"Gut serotonin is a regulator of obesity and metabolism","volume":"149","author":"Young","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.112957_bib82","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01219468","article-title":"Monoamines in the pancreatic islets of the mouse - subcellular localization of 5-hydroxytryptamine by electron microscopic autoradiography","volume":"7","author":"Ekholm","year":"1971","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.112957_bib83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1677\/joe.0.0780239","article-title":"Association between 5-hydroxytryptamine release and insulin secretion","volume":"78","author":"Gylfe","year":"1977","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2022.112957_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.1000229","article-title":"Intracellular serotonin modulates insulin secretion from pancreatic \u03b2-cells by protein serotonylation","volume":"7","author":"Paulmann","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.biopha.2022.112957_bib85","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1210\/en.2014-1687","article-title":"Functional role of serotonin in insulin secretion in a diet-induced insulin-resistant state","volume":"156","author":"Kim","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2022.112957_bib86","doi-asserted-by":"crossref","first-page":"13563","DOI":"10.1074\/jbc.274.19.13563","article-title":"Serotonin (5-hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle","volume":"274","author":"Hajduch","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib87","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nm.3766","article-title":"Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis","volume":"21","author":"Crane","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib88","article-title":"Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver","volume":"14","author":"Ko","year":"2021","journal-title":"DMM Dis. Model. Mech."},{"key":"10.1016\/j.biopha.2022.112957_bib89","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1124\/jpet.111.181834","article-title":"Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice","volume":"339","author":"Haub","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2022.112957_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07287-7","article-title":"Serotonin signals through a gut-liver axis to regulate hepatic steatosis","volume":"9","author":"Choi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.112957_bib91","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1021\/acs.jmedchem.0c00002","article-title":"Design, synthesis, and biological evaluation of new peripheral 5HT2A antagonists for nonalcoholic fatty liver disease","volume":"63","author":"Kim","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib92","article-title":"Inhibiting serotonin signaling through HTR2B in visceral adipose tissue improves obesity related insulin resistance","volume":"10","author":"Choi","year":"2021","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2022.112957_bib93","first-page":"9","article-title":"Recent progress in biological activities of indole and indole alkaloids, mini-reviews","volume":"18","author":"Singh","year":"2017","journal-title":"Med. Chem."},{"issue":"2012","key":"10.1016\/j.biopha.2022.112957_bib94","article-title":"Methanolic root extract of rauwolfia serpentina benth improves the glycemic, antiatherogenic, and cardioprotective indices in alloxan-induced diabetic mice","author":"Azmi","year":"2012","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2022.112957_bib95","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3923\/ijp.2009.323.326","article-title":"Hypoglycaemic and hypolipidemic activities of Rauwolfia serpentina in alloxan-induced diabetic rats","volume":"5","author":"Qureshi","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2022.112957_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061327","article-title":"Prospecting for novel plant-derived molecules of rauvolfia serpentina as inhibitors of aldose reductase, a potent drug target for diabetes and its complications","volume":"8","author":"Pathania","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112957_bib97","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ejps.2012.07.012","article-title":"16,17-dihydro-17b-hydroxy isomitraphylline alkaloid as an inhibitor of DPP-IV, and its effect on incretin hormone and \u03b2-cell proliferation in diabetic rat","volume":"47","author":"Shukla","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.112957_bib98","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/jps.2600610805","article-title":"Effects of certain nonsteroid anti-inflammatory drugs, tolbutamide, and tetrahydroalstonine on blood glucose and carrageenin\u2010induced pedal edema in rats","volume":"61","author":"Kocialski","year":"1972","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.112957_bib99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ptr.2650070302","article-title":"Recent advances in studies of antihyperlipaemic and antihyperglycaemic compounds from Chinese traditional and herbal medicines","volume":"7","author":"Ling\u2010Hua","year":"1993","journal-title":"Phyther. Res."},{"key":"10.1016\/j.biopha.2022.112957_bib100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0163-7258(01)00156-5","article-title":"Yohimbine: a clinical review","volume":"91","author":"Tam","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2022.112957_bib101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1574893611207040366","article-title":"Indole alkaloids as new leads for the design and development of novel DPP-IV inhibitors for the treatment of diabetes","volume":"13","author":"Dhiraviam","year":"2015","journal-title":"Curr. Bioinform."},{"key":"10.1016\/j.biopha.2022.112957_bib102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000334629","article-title":"Involvement of \u03b12-adrenoceptor subtypes a and c in glucose homeostasis and adrenaline-induced hyperglycaemia","volume":"96","author":"Ruohonen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.biopha.2022.112957_bib103","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1176827","article-title":"Overexpression of Alpha2A-Adrenergic receptors contributes to type 2 diabetes","volume":"327","author":"Rosengren","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112957_bib104","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/db16-1166","article-title":"Endogenous a2A-Adrenoceptor-operated sympathoadrenergic tones attenuate insulin secretion via cAMP\/TRPM2 signaling","volume":"66","author":"Ito","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.112957_bib105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/phrs.2001.0870","article-title":"The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists","volume":"44","author":"Abdel-Zaher","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2022.112957_bib106","first-page":"252","article-title":"The \u03b12-adrenoceptor antagonist yohimbine normalizes increased islet blood flow in GK rats: a model of type 2 diabetes","volume":"45","author":"Sandberg","year":"2013","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.biopha.2022.112957_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008284.pub2","article-title":"Blood pressure lowering efficacy of clonidine for primary hypertension","volume":"2015","author":"Musini","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2022.112957_bib108","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nchembio.1410","article-title":"VMAT2 identified as a regulator of late-stage \u03b2-cell differentiation","volume":"10","author":"Sakano","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2022.112957_bib109","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0024-3205(92)90388-6","article-title":"Effects of hirsutine, an antihypertensive indole alkaloid from Uncaria rhynchophylla, on intracellular calcium in rat thoracic aorta","volume":"50","author":"Horie","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.112957_bib110","first-page":"1","article-title":"The novel analogue of hirsutine as an anti-hypertension and vasodilatary agent both in vitro and in vivo","volume":"10","author":"Zhu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112957_bib111","first-page":"8","article-title":"Effects of ramulus uncariae et uncus on high-fat-fed obese rats ramuius ungariae et uncus","volume":"8","author":"Xia","year":"2006","journal-title":"J. Hubei CoII. TCM"},{"key":"10.1016\/j.biopha.2022.112957_bib112","first-page":"246","article-title":"Effects of Ramulus Uncariae et Uncus on body mass, food intake, serum glucose and total antioxidative ability of high-fat-fed obese rats","volume":"9","author":"Luo","year":"2005","journal-title":"Chin. J. Clin. Rehabil."},{"key":"10.1016\/j.biopha.2022.112957_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2021.105917","article-title":"Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models","volume":"177","author":"Hu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2022.112957_bib114","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejmech.2017.08.026","article-title":"Novel rhynchophylline analogues as microvascular relaxation agents for the treatment of microvascular dysfunction caused by diabetes","volume":"139","author":"Guo","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib115","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1089\/ars.2018.7721","article-title":"A novel rhynchophylline analog, Y396, Inhibits endothelial dysfunction induced by oxidative stress in diabetes through epidermal growth factor receptor","volume":"32","author":"Wang","year":"2020","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2022.112957_bib116","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.phytol.2009.11.003","article-title":"Glucose uptake stimulatory effect of akuammicine from Picralima nitida (Apocynaceae)","volume":"3","author":"Shittu","year":"2010","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.biopha.2022.112957_bib117","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.phrs.2018.12.019","article-title":"Rutaecarpine: a promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu","volume":"141","author":"ming Tian","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2022.112957_bib118","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2009.08.161","article-title":"Rutecarpine ameliorates bodyweight gain through the inhibition of orexigenic neuropeptides NPY and AgRP in mice","volume":"389","author":"Kim","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2022.112957_bib119","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbagrm.2015.10.001","article-title":"Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor","volume":"1859","author":"Yu","year":"2016","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.biopha.2022.112957_bib120","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1194\/jlr.M044198","article-title":"Rutaecarpine suppresses atherosclerosis in ApoE-\/- mice through upregulating ABCA1 and SR-BI within RCT","volume":"55","author":"Xu","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2022.112957_bib121","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/aps.2015.167","article-title":"Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1\/PI3K\/Akt and AMPK\/ACC2 signaling pathways","volume":"37","author":"Nie","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2022.112957_bib122","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jphs.2020.04.008","article-title":"Rutaecarpine exhibits anti-diabetic potential in high fat diet\u2013multiple low dose streptozotocin induced type 2 diabetic mice and in vitro by modulating hepatic glucose homeostasis","volume":"143","author":"Surbala","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2022.112957_bib123","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1021\/cb4003893","article-title":"Rutaecarpine analogues reduce lipid accumulation in adipocytes via inhibiting adipogenesis\/lipogenesis with AMPK activation and UPR suppression","volume":"8","author":"Chen","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biopha.2022.112957_bib124","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1016\/j.bmc.2015.05.057","article-title":"Discovery of natural alkaloid bouchardatine as a novel inhibitor of adipogenesis\/lipogenesis in 3T3-L1 adipocytes","volume":"23","author":"Rao","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib125","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/bph.13855","article-title":"Natural alkaloid bouchardatine ameliorates metabolic disorders in high-fat diet-fed mice by stimulating the sirtuin 1\/liver kinase B-1\/AMPK axis","volume":"174","author":"Rao","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112957_bib126","doi-asserted-by":"crossref","first-page":"9395","DOI":"10.1021\/acs.jmedchem.5b01566","article-title":"Synthesis and biological evaluation of novel bouchardatine derivatives as potential adipogenesis\/lipogenesis inhibitors for antiobesity treatment","volume":"58","author":"Rao","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib127","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1111\/bph.14713","article-title":"Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease\/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity","volume":"176","author":"Rao","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112957_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112172","article-title":"Discovery of a promising agent IQZ23 for the treatment of obesity and related metabolic disorders","volume":"192","author":"Rao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib129","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1055\/s-2001-17353","article-title":"Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist","author":"Kobayashi","year":"2001","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2022.112957_bib130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/en.2007-0467","article-title":"Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: Involvement of antiadipogenic mechanism and extracellularly regulated kinase\/mitogen-activated protein kinase signaling","volume":"149","author":"Wang","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2022.112957_bib131","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ijo.2009.223","article-title":"Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes","volume":"34","author":"Bak","year":"2010","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2022.112957_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0083264","article-title":"Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese\/diabetic mice","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112957_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5082817","article-title":"Evodiamine attenuates p2x 7 -mediated inflammatory injury of human umbilical vein endothelial cells exposed to high free fatty acids","volume":"2018","author":"Xue","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2022.112957_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8565760","article-title":"Catharanthus roseus combined with ursolic acid attenuates streptozotocin-induced diabetes through insulin secretion and glycogen storage","volume":"2020","author":"Alkreathy","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2022.112957_bib135","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.3390\/molecules18089770","article-title":"Antidiabetic and antioxidant properties of alkaloids from Catharanthus roseus (L.) G. Don","volume":"18","author":"Tiong","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.112957_bib136","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.fitote.2015.01.019","article-title":"Vindogentianine, a hypoglycemic alkaloid from Catharanthus roseus (L.) G. Don (Apocynaceae)","volume":"102","author":"Tiong","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2022.112957_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom9100544","article-title":"Molecular docking of isolated alkaloids for possible \u03b1-glucosidase inhibition","volume":"9","author":"Rahman","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2022.112957_bib138","first-page":"252","article-title":"In silico molecular modeling and docking studies of catharanthus roseus derived alkaloids against GLUT4","volume":"3","author":"Volume","year":"2015","journal-title":"Int. J. Curr. Res. Acad. Rev."},{"key":"10.1016\/j.biopha.2022.112957_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2019.108638","article-title":"Vindoline effectively ameliorated diabetes-induced hepatotoxicity by docking oxidative stress, inflammation and hypertriglyceridemia in type 2 diabetes-induced male Wistar rats","volume":"112","author":"Goboza","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112957_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines7030059","article-title":"Vindoline\u2014a natural product from Catharanthus roseus reduces hyperlipidemia and renal pathophysiology in experimental type 2 diabetes","volume":"7","author":"Oguntibeju","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2022.112957_bib141","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jep.2013.08.043","article-title":"Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models","volume":"150","author":"Yao","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2022.112957_bib142","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.bmcl.2016.09.064","article-title":"Synthesis and glucose-stimulate insulin secretion (GSIS) evaluation of vindoline derivatives","volume":"27","author":"Xiao","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.112957_bib143","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3329\/jsr.v1i2.1075","article-title":"Antidiabetic and hypolipidemic effects of different fractions of Catharanthus roseus (Linn.) on normal and streptozotocin-induced diabetic rats","volume":"1","author":"Islam","year":"2009","journal-title":"J. Sci. Res."},{"key":"10.1016\/j.biopha.2022.112957_bib144","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00280-015-2924-3","article-title":"In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine","volume":"77","author":"Fandy","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112957_bib145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2018.11.034","article-title":"Antidiabetic, antihyperlipidemic and antioxidant effect of Vincamine, in streptozotocin-induced diabetic rats","volume":"843","author":"Nandini","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2022.112957_bib146","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/JOE-18-0432","article-title":"Vincamine as a GPR40 agonist improves glucose homeostasis in type 2 diabetic mice","volume":"240","author":"Du","year":"2019","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2022.112957_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.111976","article-title":"Design, synthesis and biological evaluation of vincamine derivatives as potential pancreatic \u03b2-cells protective agents for the treatment of type 2 diabetes mellitus","volume":"188","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib148","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1002\/anie.201100981","article-title":"Total synthesis of (-)-conophylline and (-)-conophyllidine","volume":"50","author":"Han-Ya","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2022.112957_bib149","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jep.2014.05.055","article-title":"The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations","volume":"155","author":"Ezuruike","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2022.112957_bib150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0753-3322(03)00096-9","article-title":"Induction of insulin production in rat pancreatic acinar carcinoma cells by conophylline","volume":"57","author":"Umezawa","year":"2003","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112957_bib151","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.biopha.2004.10.003","article-title":"Screening of bioactive metabolites for pancreatic regeneration chemotherapy","volume":"58","author":"Takatsuna","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112957_bib152","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/en.2011-1767","article-title":"Conophylline suppresses pancreatic stellate cells and improves islet fibrosis in Goto-Kakizaki rats","volume":"153","author":"Saito","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2022.112957_bib153","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.biopha.2009.01.006","article-title":"Antidiabetic effect of orally administered conophylline-containing plant extract on streptozotocin-treated and Goto-Kakizaki rats","volume":"63","author":"Fujii","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112957_bib154","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1507\/endocrj.K09E-158","article-title":"Administration of conophylline and betacellulin-\u03b44 increases the \u03b2-cell mass in neonatal streptozotocin-treated rats","volume":"56","author":"Kodera","year":"2009","journal-title":"Endocr. J."},{"key":"10.1016\/j.biopha.2022.112957_bib155","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.2337\/diabetes.53.10.2596","article-title":"Promotion of \u03b2-cell differentiation by conophylline in fetal and neonatal rat pancreas","volume":"53","author":"Ogata","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.112957_bib156","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biopha.2009.09.025","article-title":"Promotion of \u03b2-cell differentiation by the alkaloid conophylline in porcine pancreatic endocrine cells","volume":"64","author":"Kawakami","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112957_bib157","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.biocel.2005.09.019","article-title":"Conophylline: a novel differentiation inducer for pancreatic \u03b2 cells","volume":"38","author":"Kojima","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2022.112957_bib158","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/liv.12328","article-title":"Conophylline suppresses hepatic stellate cells and attenuates thioacetamide-induced liver fibrosis in rats","volume":"34","author":"Kubo","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2022.112957_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0178436","article-title":"Conophylline inhibits non-alcoholic steatohepatitis in mice","volume":"12","author":"Nakade","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112957_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0210068","article-title":"Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice","volume":"14","author":"Ohashi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112957_bib161","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cmet.2007.03.010","article-title":"The small molecule harmine is an antidiabetic cell-type-specific regulator of PPAR\u03b3 expression","volume":"5","author":"Waki","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.112957_bib162","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cmet.2007.04.006","article-title":"Targeting fat to prevent diabetes","volume":"5","author":"Sethi","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.112957_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep36382","article-title":"Harmine Induces Adipocyte Thermogenesis through RAC1-MEK-ERK-CHD4 Axis","volume":"6","author":"Nie","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.112957_bib164","doi-asserted-by":"crossref","first-page":"E859","DOI":"10.1152\/ajpendo.00515.2015","article-title":"Development of a reliable automated screening system to identify small molecules and biologics that promote human \u03b2-cell regeneration","volume":"311","author":"Aamodt","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.112957_bib165","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","article-title":"A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication","volume":"21","author":"Wang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.132594","article-title":"Pharmacologic and genetic approaches define human pancreatic \u03b2 cell mitogenic targets of DYRK1A inhibitors","volume":"5","author":"Ackeifi","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2022.112957_bib167","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1021\/acs.jmedchem.8b00658","article-title":"Development of kinase-selective, harmine-based DYRK1A inhibitors that induce pancreatic human \u03b2-Cell proliferation","volume":"61","author":"Kumar","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib168","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1021\/acs.jmedchem.9b01379","article-title":"Synthesis and biological validation of a harmine-based, central nervous system (CNS)-avoidant, selective, human \u03b2-cell regenerative dual-specificity tyrosine phosphorylation-regulated kinase A (DYRK1A) inhibitor","volume":"63","author":"Kumar","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib169","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.phrs.2007.08.002","article-title":"The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo","volume":"56","author":"Li","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2022.112957_bib170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejphar.2012.10.006","article-title":"A novel indole derivative compound GY3 improves glucose and lipid metabolism via activation of AMP-activated protein kinase pathway","volume":"698","author":"Si","year":"2013","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2022.112957_bib171","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/s41401-018-0208-2","article-title":"Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice","volume":"40","author":"ting Zhou","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2022.112957_bib172","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cell.2017.03.001","article-title":"Selective chemical inhibition of PGC-1\u03b1 gluconeogenic activity ameliorates type 2 diabetes","volume":"169","author":"Sharabi","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.112957_bib173","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1073\/pnas.0502983102","article-title":"MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes","volume":"102","author":"Erion","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.112957_bib174","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1021\/jm800720a","article-title":"Novel Heteroaromatic Organofluorine Inhibitors of Fructose-1,6-bisphosphatase","volume":"52","author":"Rudnitskaya","year":"2009","journal-title":"J. Med. Chem. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/cmdc.200900493","article-title":"Rational design, synthesis, and potency of N-substituted indoles, pyrroles, and triarylpyrazoles as potential fructose 1,6-bisphosphatase inhibitors","volume":"5","author":"Rudnitskaya","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biopha.2022.112957_bib176","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0960-894X(03)00310-X","article-title":"3-(2-Carboxy-ethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site","volume":"13","author":"Wright","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.112957_bib177","first-page":"1850","article-title":"Design, synthesis and biological evaluation of 7-nitro-1H-indole-2- carboxylic acid derivatives as allosteric inhibitors of fructose-1,6- bisphosphatase, Bioorganic","volume":"22","author":"Bie","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib178","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejmech.2014.11.049","article-title":"Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase","volume":"90","author":"Bie","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib179","doi-asserted-by":"crossref","first-page":"10307","DOI":"10.1021\/acs.jmedchem.0c00726","article-title":"Discovery of N-arylsulfonyl-indole-2-carboxamide derivatives as potent, selective, and orally bioavailable fructose-1,6-bisphosphatase inhibitors - design, synthesis, in vivo glucose lowering effects, and X-ray crystal complex analysis","volume":"63","author":"Zhou","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib180","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1021\/acs.jnatprod.9b00620","article-title":"Indole-diterpenoids with protein tyrosine phosphatase inhibitory activities from the marine-derived fungus penicillium sp. KFD28","volume":"82","author":"Zhou","year":"2019","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2022.112957_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/md16030097","article-title":"Function-oriented synthesis of marine phidianidine derivatives as potential PTP1B inhibitors with specific selectivity","volume":"16","author":"Liu","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.biopha.2022.112957_bib182","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1016\/j.bmcl.2012.10.054","article-title":"Discovery of di-indolinone as a novel scaffold for protein tyrosine phosphatase 1B inhibitors","volume":"22","author":"Dai","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.112957_bib183","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.fitote.2016.02.011","article-title":"Secondary metabolites from the flower buds of Lonicera japonica and their in vitro anti-diabetic activities","volume":"110","author":"Liu","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2022.112957_bib184","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejmech.2013.09.017","article-title":"Design, synthesis, and biological evaluation of novel 2-ethyl-5- phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy","volume":"69","author":"Chen","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib185","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00125-018-4654-7","article-title":"Development of SGLT1 and SGLT2 inhibitors","volume":"61","author":"Rieg","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.112957_bib186","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejmech.2012.06.053","article-title":"Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors","volume":"55","author":"Yao","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib187","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.bmcl.2005.12.006","article-title":"Indole-glucosides as novel sodium glucose co-transporter 2 (SGLT2) inhibitors. Part 2","volume":"16","author":"Zhang","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.112957_bib188","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1021\/ml400339b","article-title":"Novel indole\u2011N\u2011glucoside, TA-1887 as a sodium glucose cotransporter 2 inhibitor for treatment of type 2 diabetes","volume":"5","author":"Nomura","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.112957_bib189","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bioorg.2018.11.006","article-title":"Synthesis and biological evaluation of N-glucosyl indole derivatives as sodium-dependent glucose co-transporter 2 inhibitors","volume":"83","author":"Chu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112523","article-title":"An exhaustive perspective on structural insights of SGLT2 inhibitors: a novel class of antidiabetic agent","volume":"204","author":"Bhattacharya","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib191","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1016\/j.bmcl.2004.06.057","article-title":"Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target","volume":"14","author":"Lehmann","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.112957_bib192","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2022.112957_bib193","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/acs.accounts.6b00265","article-title":"Cyclohepta[b]indoles: a privileged structure motif in natural products and drug design","volume":"49","author":"Stempel","year":"2016","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2022.112957_bib194","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bmcl.2009.01.084","article-title":"N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors","volume":"19","author":"Barf","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.112957_bib195","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejmech.2012.03.006","article-title":"Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes","volume":"52","author":"Xu","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib196","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejmech.2017.07.022","article-title":"Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. a comprehensive systematic review","volume":"138","author":"Floresta","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib197","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1517\/13543776.2016.1131268","article-title":"Glycogen phosphorylase inhibitors: a patent review (2013-2015)","volume":"26","author":"Donnier-Mar\u00e9chal","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2022.112957_bib198","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.bmc.2008.04.010","article-title":"Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase \u03b1","volume":"16","author":"Onda","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib199","doi-asserted-by":"crossref","first-page":"10001","DOI":"10.1016\/j.bmc.2008.10.021","article-title":"Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors","volume":"16","author":"Onda","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"378","author":"Tahrani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.112957_bib201","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1021\/jm0208572","article-title":"Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1h-indol-4ylmethylene]hydrazide","volume":"45","author":"Madsen","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib202","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1016\/j.bmcl.2011.09.105","article-title":"Discovery of N-Aryl-2-acylindole human glucagon receptor antagonists","volume":"21","author":"Sinz","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.112957_bib203","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.bmcl.2019.05.036","article-title":"Design, synthesis and structure activity relationships of indazole and indole derivatives as potent glucagon receptor antagonists","volume":"29","author":"Song","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.112957_bib204","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1021\/jm0492094","article-title":"Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications","volume":"48","author":"Van Zandt","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib205","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s11064-019-02736-1","article-title":"3-Mercapto-5H-1,2,4-Triazino[5,6-b]Indole-5-acetic acid (Cemtirestat) Alleviates Symptoms of Peripheral Diabetic Neuropathy in Zucker Diabetic Fatty (ZDF) rats: a role of aldose reductase","volume":"44","author":"Soltesova Prnova","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2022.112957_bib206","first-page":"75","article-title":"Effects of treatmentwith melatonin and tryptophan on liver enzymes, parametrs of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease - 14 months follow up","volume":"65","author":"Celinski","year":"2014","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112957_bib207","first-page":"577","article-title":"The effects of l-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis","volume":"61","author":"Cichoz-Lach","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112957_bib208","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1021\/acs.jmedchem.6b01593","article-title":"Diindolylmethane derivatives: potent agonists of the immunostimulatory orphan G protein-coupled receptor GPR84","volume":"60","author":"Pillaiyar","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib209","first-page":"1","article-title":"Decoy bypass for appetite suppression in obese adults: role of synergistic nutrient sensing receptors GPR84 and FFAR4 on colonic endocrine cells","author":"Peiris","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2022.112957_bib210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3009934","article-title":"Genotype-based treatment of type 2 diabetes with an \u03b12A-adrenergic receptor antagonist","volume":"6","author":"Tang","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib211","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2337\/db06-0883","article-title":"Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice","volume":"56","author":"Ayala","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.112957_bib212","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2337\/dc08-1862","article-title":"Phosphodiesterase 5 inhibition improves \u03b2-cell function in metabolic syndrome","volume":"32","author":"Hill","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.112957_bib213","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/17843286.2017.1293759","article-title":"Effect of tadalafil administration on insulin secretion and insulin sensitivity in obese men","volume":"72","author":"Gonz\u00e1lez-Ortiz","year":"2017","journal-title":"Acta Clin. Belgica Int. J. Clin. Lab. Med"},{"key":"10.1016\/j.biopha.2022.112957_bib214","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s12020-016-1208-y","article-title":"Tadalafil improves lean mass and endothelial function in nonobese men with mild ED\/LUTS: in vivo and in vitro characterization","volume":"56","author":"Aversa","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.biopha.2022.112957_bib215","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/dme.12999","article-title":"Postprandial effects of the phosphodiesterase-5 inhibitor tadalafil in people with well-controlled Type 2 diabetes mellitus: a randomized controlled trial","volume":"33","author":"Sj\u00f6gren","year":"2016","journal-title":"Diabet. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib216","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1463-1326.2010.01304.x","article-title":"Bromocriptine: Old drug, new formulation and new indication","volume":"12","author":"Holt","year":"2010","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.biopha.2022.112957_bib217","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2337\/diacare.23.8.1154","article-title":"Bromocriptine: a novel approach to the treatment of type 2 diabetes","volume":"23","author":"Pijl","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.112957_bib218","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2337\/dc09-2009","article-title":"Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes","volume":"33","author":"Gaziano","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.112957_bib219","first-page":"1","article-title":"Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects","volume":"1","author":"Michael Gaziano","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2022.112957_bib220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3810\/pgm.2012.09.2598","article-title":"Focusing on cardiovascular disease in type 2 diabetes mellitus: An introduction to bromocriptine QR","volume":"124","author":"Bell","year":"2012","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib221","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.112957_bib222","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1021\/jm0506930","article-title":"Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities","volume":"48","author":"Mahindroo","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib223","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1021\/jm0510373","article-title":"Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies","volume":"49","author":"Mahindroo","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib224","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/acs.jmedchem.7b01285","article-title":"Design, synthesis, and evaluation of a novel series of indole sulfonamide peroxisome proliferator activated receptor (PPAR) \u03b1\/\u03b3\/\u03b4 triple activators: discovery of lanifibranor, a new antifibrotic clinical candidate","volume":"61","author":"Boubia","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib225","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hep4.1057","article-title":"The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis","volume":"1","author":"Wettstein","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.biopha.2022.112957_bib226","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2020.04.025","article-title":"Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages","volume":"73","author":"Lefere","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2022.112957_bib227","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jhep.2020.11.045","article-title":"Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease","volume":"74","author":"Boyer-Diaz","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2022.112957_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.106170","article-title":"A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study","volume":"98","author":"Sven M","year":"2020","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.biopha.2022.112957_bib229","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the Pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib230","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.112957_bib231","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.apsb.2018.09.007","article-title":"Small molecules for fat combustion: targeting obesity","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.112957_bib232","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.2337\/dc15-S010","article-title":"Approaches to glycemic treatment","volume":"38","author":"Control","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.112957_bib233","first-page":"4002","article-title":"A review on medication of diabetes mellitus and antidiabetic medicinal plants","volume":"4","author":"Abdel-Moneim","year":"2015","journal-title":"Int. J. Bioassays"},{"key":"10.1016\/j.biopha.2022.112957_bib234","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2174\/138955709788452649","article-title":"From nature to drug discovery: the indole scaffold as a \u2018privileged structure","volume":"9","author":"de Sa Alves","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112957_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112506","article-title":"The importance of indole and azaindole scaffold in the development of antitumor agents","volume":"203","author":"Han","year":"2020","journal-title":"Eur. J. Med. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:45:11Z","timestamp":1780487111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222003468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":235,"alternative-id":["S0753332222003468"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112957","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update of Indoles: Promising molecules for ameliorating metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112957"}}